Photo by Mary Donaldson
David D'Alessio, M.D., of the University of Cincinnati (second from left), is greeted by Kevin Niswender, M.D., Ph.D., Darryl Granner, M.D.,and Steven Gabbe, M.D., at the Eskind Diabetes Research Symposium last week. Speakers from Vanderbilt, the University of Toronto, and Novartis discussed new therapies that have shown promise in treating Type 2 diabetes. The symposium, planned to be held annually, was made possible by a gift from the Eskind family, whose support also established the Vanderbilt-Eskind Diabetes Clinic, which opened last year.